Tania Small

Tania Small is a highly accomplished professional with a robust background in the medical oncology and pharmaceutical industry.

She currently serves as the Vice President and Global Medical Oncology Franchise Head at GSK, bringing valuable expertise and leadership to the role.

Prior to her current position, Tania was the CEO and Founder of Beacon Medical Pathway Inc, showcasing her entrepreneurial spirit and ability to drive innovative healthcare solutions.

Her extensive career includes notable roles such as Vice President-Head of Oncology Global Drug Development at Ipsen, where she played a key role in drug development strategies.

Tania also held significant positions at renowned organizations like Novartis and Sangart, where she contributed as a Senior Medical Director, Medical Director, and Global Medical Director/Therapeutic Lead.

With a solid foundation in pediatric hematology, oncology, and bone marrow transplants, Tania has a wealth of experience from her time as a physician at New York Presbyterian Hospital.

Her diverse professional journey and impactful contributions have solidified her reputation as a leader in the field of medical oncology and drug development.

Tania Small's multifaceted career trajectory reflects her commitment to advancing healthcare, driving innovation, and improving patient outcomes.

Her strategic vision and deep industry knowledge make her a highly respected figure in the pharmaceutical and medical community.